Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2013-11-21
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ARTHRITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-28 (study day 38.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.